Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
Land SR, Kopec JA, Yothers G, Anderson S, Day R, Tang G, Ganz PA, Fisher B, Wolmark N. Land SR, et al. Breast Cancer Res Treat. 2004 Jul;86(2):153-64. doi: 10.1023/B:BREA.0000032983.87966.4e. Breast Cancer Res Treat. 2004. PMID: 15319567 Clinical Trial.
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
Land SR, Kopec JA, Cecchini RS, Ganz PA, Wieand HS, Colangelo LH, Murphy K, Kuebler JP, Seay TE, Needles BM, Bearden JD 3rd, Colman LK, Lanier KS, Pajon ER Jr, Cella D, Smith RE, O'Connell MJ, Costantino JP, Wolmark N. Land SR, et al. J Clin Oncol. 2007 Jun 1;25(16):2205-11. doi: 10.1200/JCO.2006.08.6652. Epub 2007 Apr 30. J Clin Oncol. 2007. PMID: 17470850 Clinical Trial.
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.
Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, Christian NJ, Costantino JP, Wolmark N, Ganz PA. Land SR, et al. J Clin Oncol. 2010 Sep 1;28(25):3929-36. doi: 10.1200/JCO.2010.28.2491. Epub 2010 Aug 2. J Clin Oncol. 2010. PMID: 20679600 Free PMC article. Clinical Trial.
Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.
Ganz PA, Land SR, Geyer CE Jr, Cecchini RS, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff JA, Vogel VG, Erban JK, Livingston RB, Perez EA, Mamounas EP, Wolmark N, Swain SM. Ganz PA, et al. Among authors: land sr. J Clin Oncol. 2011 Mar 20;29(9):1110-6. doi: 10.1200/JCO.2010.29.7689. Epub 2011 Feb 7. J Clin Oncol. 2011. PMID: 21300930 Free PMC article. Clinical Trial.
Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial.
Land SR, Cronin WM, Wickerham DL, Costantino JP, Christian NJ, Klein WM, Ganz PA. Land SR, et al. Cancer Prev Res (Phila). 2011 Sep;4(9):1393-400. doi: 10.1158/1940-6207.CAPR-11-0172. Epub 2011 Aug 23. Cancer Prev Res (Phila). 2011. PMID: 21862698 Free PMC article. Clinical Trial.
Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01.
Kidwell KM, Yothers G, Ganz PA, Land SR, Ko CY, Cecchini RS, Kopec JA, Wolmark N. Kidwell KM, et al. Among authors: land sr. Cancer. 2012 Nov 15;118(22):5614-22. doi: 10.1002/cncr.27593. Epub 2012 May 8. Cancer. 2012. PMID: 22569841 Free PMC article. Clinical Trial.
114 results